450 related articles for article (PubMed ID: 29872621)
21. Chondrogenic differentiation of rat MSCs on porous scaffolds of silk fibroin/chitosan blends.
Bhardwaj N; Kundu SC
Biomaterials; 2012 Apr; 33(10):2848-57. PubMed ID: 22261099
[TBL] [Abstract][Full Text] [Related]
22. Silk coatings on PLGA and alginate microspheres for protein delivery.
Wang X; Wenk E; Hu X; Castro GR; Meinel L; Wang X; Li C; Merkle H; Kaplan DL
Biomaterials; 2007 Oct; 28(28):4161-9. PubMed ID: 17583788
[TBL] [Abstract][Full Text] [Related]
23. Functional hepatocyte clusters on bioactive blend silk matrices towards generating bioartificial liver constructs.
Janani G; Nandi SK; Mandal BB
Acta Biomater; 2018 Feb; 67():167-182. PubMed ID: 29223705
[TBL] [Abstract][Full Text] [Related]
24. CD44-specific nanoparticles for redox-triggered reactive oxygen species production and doxorubicin release.
Lin CW; Lu KY; Wang SY; Sung HW; Mi FL
Acta Biomater; 2016 Apr; 35():280-92. PubMed ID: 26853764
[TBL] [Abstract][Full Text] [Related]
25. Surface functionalization of methotrexate-loaded chitosan nanoparticles with hyaluronic acid/human serum albumin: Comparative characterization and in vitro cytotoxicity.
Hashad RA; Ishak RA; Geneidi AS; Mansour S
Int J Pharm; 2017 Apr; 522(1-2):128-136. PubMed ID: 28279742
[TBL] [Abstract][Full Text] [Related]
26. Spermine-modified Antheraea pernyi silk fibroin as a gene delivery carrier.
Yu Y; Hu Y; Li X; Liu Y; Li M; Yang J; Sheng W
Int J Nanomedicine; 2016; 11():1013-23. PubMed ID: 27042056
[TBL] [Abstract][Full Text] [Related]
27. Enhanced delivery of artemisinin and its analogues to cancer cells by their adducts with human serum transferrin.
Yang Y; Zhang X; Wang X; Zhao X; Ren T; Wang F; Yu B
Int J Pharm; 2014 Jun; 467(1-2):113-22. PubMed ID: 24661944
[TBL] [Abstract][Full Text] [Related]
28. Chitosan-based polyelectrolyte complexes as potential nanoparticulate carriers: physicochemical and biological characterization.
Ramasamy T; Tran TH; Cho HJ; Kim JH; Kim YI; Jeon JY; Choi HG; Yong CS; Kim JO
Pharm Res; 2014 May; 31(5):1302-14. PubMed ID: 24297070
[TBL] [Abstract][Full Text] [Related]
29. Physically crosslinked silk fibroin/hyaluronic acid scaffolds.
Guan Y; You H; Cai J; Zhang Q; Yan S; You R
Carbohydr Polym; 2020 Jul; 239():116232. PubMed ID: 32414432
[TBL] [Abstract][Full Text] [Related]
30. Periosteum and development of the tissue-engineered periosteum for guided bone regeneration.
Zhang W; Wang N; Yang M; Sun T; Zhang J; Zhao Y; Huo N; Li Z
J Orthop Translat; 2022 Mar; 33():41-54. PubMed ID: 35228996
[TBL] [Abstract][Full Text] [Related]
31. Platelet extracellular vesicles are efficient delivery vehicles of doxorubicin, an anti-cancer drug: preparation and in vitro characterization.
Wu YW; Lee DY; Lu YL; Delila L; Nebie O; Barro L; Changou CA; Lu LS; Goubran H; Burnouf T
Platelets; 2023 Dec; 34(1):2237134. PubMed ID: 37580876
[TBL] [Abstract][Full Text] [Related]
32. Cooperative Assembly of a Peptide Gelator and Silk Fibroin Afford an Injectable Hydrogel for Tissue Engineering.
Cheng B; Yan Y; Qi J; Deng L; Shao ZW; Zhang KQ; Li B; Sun Z; Li X
ACS Appl Mater Interfaces; 2018 Apr; 10(15):12474-12484. PubMed ID: 29584396
[TBL] [Abstract][Full Text] [Related]
33. Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy.
Babu A; Amreddy N; Muralidharan R; Pathuri G; Gali H; Chen A; Zhao YD; Munshi A; Ramesh R
Sci Rep; 2017 Nov; 7(1):14674. PubMed ID: 29116098
[TBL] [Abstract][Full Text] [Related]
34. The cardiomyogenic differentiation of rat mesenchymal stem cells on silk fibroin-polysaccharide cardiac patches in vitro.
Yang MC; Wang SS; Chou NK; Chi NH; Huang YY; Chang YL; Shieh MJ; Chung TW
Biomaterials; 2009 Aug; 30(22):3757-65. PubMed ID: 19410289
[TBL] [Abstract][Full Text] [Related]
35. Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status.
van der Meel R; Vehmeijer LJ; Kok RJ; Storm G; van Gaal EV
Adv Drug Deliv Rev; 2013 Oct; 65(10):1284-98. PubMed ID: 24018362
[TBL] [Abstract][Full Text] [Related]
36. Silk Fibroin Based Drug Delivery Applications: Promises and Challenges.
Wani SUD; Veerabhadrappa GH
Curr Drug Targets; 2018; 19(10):1177-1190. PubMed ID: 29283071
[TBL] [Abstract][Full Text] [Related]
37. Receptor-mediated targeted drug delivery systems for treatment of inflammatory bowel disease: Opportunities and emerging strategies.
Liu P; Gao C; Chen H; Vong CT; Wu X; Tang X; Wang S; Wang Y
Acta Pharm Sin B; 2021 Sep; 11(9):2798-2818. PubMed ID: 34589398
[TBL] [Abstract][Full Text] [Related]
38. Hyaluronic Acid-Decorated Glycol Chitosan Nanoparticles for pH-Sensitive Controlled Release of Doxorubicin and Celecoxib in Nonsmall Cell Lung Cancer.
Lee R; Choi YJ; Jeong MS; Park YI; Motoyama K; Kim MW; Kwon SH; Choi JH
Bioconjug Chem; 2020 Mar; 31(3):923-932. PubMed ID: 32027493
[TBL] [Abstract][Full Text] [Related]
39. EGFR Targeted Cetuximab-Valine-Citrulline (vc)-Doxorubicin Immunoconjugates- Loaded Bovine Serum Albumin (BSA) Nanoparticles for Colorectal Tumor Therapy.
Ye Z; Zhang Y; Liu Y; Liu Y; Tu J; Shen Y
Int J Nanomedicine; 2021; 16():2443-2459. PubMed ID: 33814909
[TBL] [Abstract][Full Text] [Related]
40. Hyaluronic acid and Arg-Gly-Asp peptide modified Graphene oxide with dual receptor-targeting function for cancer therapy.
Guo Y; Xu H; Li Y; Wu F; Li Y; Bao Y; Yan X; Huang Z; Xu P
J Biomater Appl; 2017 Jul; 32(1):54-65. PubMed ID: 28554233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
